Cancer of the breast: morphological changes after peritumoral BCG as new parameters to choice of treatment and prognosis.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D009163:Mycobacterium bovis
D000970:Antineoplastic Agents